NCLEX Prep: Cardiac Disorder Review

Your ability to expertly manage cardiac disorders is a cornerstone of safe nursing practice and a significant focus of the NCLEX-RN® examination. This review synthesizes the essential pathophysiological concepts, clinical assessments, and priority interventions you must master to answer questions confidently, whether they involve interpreting a rhythm strip or choosing the next critical action for a patient in crisis.

Understanding Heart Failure: Classifications and Compensatory Mechanisms

Heart failure (HF) is a clinical syndrome where the heart is unable to pump sufficient blood to meet the body’s metabolic demands. For the NCLEX, you must differentiate between the two main types: systolic heart failure (reduced ejection fraction, HFrEF) and diastolic heart failure (preserved ejection fraction, HFpEF). Think of systolic failure as a weak pump and diastolic failure as a stiff, non-compliant ventricle that cannot fill properly.

The body attempts to compensate for poor cardiac output through neurohormonal activation. The renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system kick in, causing vasoconstriction, increased heart rate, and fluid retention. While initially helpful, these compensatory mechanisms ultimately increase the heart’s workload (afterload) and volume (preload), leading to a vicious cycle of worsening failure. This is why drugs that block these systems—like ACE inhibitors and beta-blockers—are cornerstone therapies.

Clinical presentation is often framed by the New York Heart Association (NYHA) Functional Classification (Class I-IV, based on symptom limitation) and the American College of Cardiology/American Heart Association (ACC/AHA) Stages (Stage A-D, which emphasize disease progression and prevention). A common NCLEX scenario involves identifying left-sided versus right-sided failure. Left-sided heart failure typically presents with pulmonary symptoms: dyspnea, orthopnea, paroxysmal nocturnal dyspnea, and crackles. Right-sided heart failure manifests with systemic signs: jugular venous distention (JVD), hepatomegaly, ascites, and dependent peripheral edema.

Dysrhythmia Recognition and Emergency Interventions

Accurate dysrhythmia recognition begins with a systematic analysis of a rhythm strip: assess rate, regularity, P wave presence/morphology, PR interval, and QRS duration. You must be able to identify lethal rhythms requiring immediate intervention.

The two primary arrest rhythms are ventricular fibrillation (VFib) and pulseless ventricular tachycardia (VTach). These are “shockable” rhythms, and the immediate intervention is defibrillation. In contrast, asystole and pulseless electrical activity (PEA) are “non-shockable”; treatment focuses on high-quality CPR and identifying reversible causes (remember the H’s and T’s: Hypoxia, Hypovolemia, etc.).

For non-lethal but potentially dangerous rhythms, understand the nursing priorities. Atrial fibrillation carries a high risk of stroke due to clot formation in the stagnant blood of the atria; a key nursing role is ensuring anticoagulation therapy is administered and monitored. Third-degree AV block (complete heart block) is characterized by no relationship between P waves and QRS complexes; the atria and ventricles beat independently. This often requires emergency transcutaneous pacing, with atropine being a temporary bridge. Always correlate the rhythm with the patient’s clinical condition—a rhythm is only treated if it is causing symptoms like hypotension, chest pain, or altered mental status.

Acute Coronary Syndrome (ACS) Management

Acute coronary syndrome (ACS) is an umbrella term for conditions where blood supply to the heart muscle is suddenly blocked. It encompasses unstable angina, NSTEMI (non-ST-elevation myocardial infarction), and STEMI (ST-elevation myocardial infarction). The pathophysiological hallmark is plaque rupture in a coronary artery, leading to thrombus formation and vessel occlusion.

Your initial assessment for suspected ACS follows the “MONA” mnemonic, though not in sequence of administration: Morphine (for pain and anxiety), Oxygen (only if hypoxic), Nitroglycerin (sublingual to relieve pain and dilate vessels), and Aspirin (162-325 mg chewed to inhibit platelet aggregation). The priority is a 12-lead ECG within 10 minutes of arrival. A STEMI, identified by ST-segment elevation, is a true emergency requiring immediate reperfusion therapy—either percutaneous coronary intervention (PCI) within 90 minutes or fibrinolytic therapy (“clot-busters” like alteplase) if PCI is not available.

Post-ACS care focuses on reducing cardiac workload and preventing further damage. This includes continuous monitoring for complications like heart failure or lethal dysrhythmias, administering beta-blockers to decrease heart rate and contractility, and providing patient education on cardiac rehabilitation and secondary prevention (e.g., strict adherence to antiplatelet therapy like clopidogrel).

Cardiac Medication Administration and Monitoring

Administering cardiac medications requires an understanding of their action, key monitoring parameters, and major side effects. These drugs are often high-alert medications.

• ACE Inhibitors (e.g., lisinopril) & ARBs (e.g., valsartan): First-line for HF and post-MI. They reduce afterload. Monitor for hypotension, hyperkalemia, and a persistent dry cough (ACEIs only). Assess renal function before and during therapy.
• Beta-Blockers (e.g., metoprolol, carvedilol): Decrease heart rate, blood pressure, and myocardial oxygen demand. Never abruptly stop these drugs. Monitor for bradycardia, hypotension, and masking of hypoglycemia symptoms. Use with caution in patients with asthma (cardioselective ones like metoprolol are preferred).
• Diuretics: Loop diuretics (e.g., furosemide) are first-line for acute fluid overload in HF. Monitor for electrolyte depletion (especially potassium), dehydration, and ototoxicity. Thiazide diuretics (e.g., hydrochlorothiazide) are used for hypertension. Potassium-sparing diuretics (e.g., spironolactone) are used in advanced HF; monitor for hyperkalemia.
• Antidysrhythmics: Know the key antidotes. For digoxin toxicity (signs: nausea, vision changes, bradycardia), the antidote is digoxin immune fab. For warfarin over-anticoagulation, the antidote is vitamin K (or fresh frozen plasma for severe bleeding). For heparin over-anticoagulation, the antidote is protamine sulfate.
• Antiplatelets/Anticoagulants: Understand the difference. Antiplatelets (e.g., aspirin, clopidogrel) prevent platelet aggregation. Anticoagulants (e.g., warfarin, heparin, direct oral anticoagulants/DOACs) affect the clotting cascade. Major monitoring for warfarin is the INR (therapeutic range is typically 2.0-3.0); for heparin, it’s the aPTT or anti-Xa level.

Common Pitfalls

1. Misclassifying Heart Failure: Confusing left-sided and right-sided symptoms. Remember: Left = Lungs (crackles, dyspnea). Right = Rest of body (JVD, peripheral edema). Biventricular failure involves both.
2. Treating the Rhythm, Not the Patient: Recommending immediate treatment for a stable, asymptomatic dysrhythmia. The NCLEX prioritizes intervention only when the rhythm causes hemodynamic instability (e.g., hypotension, chest pain, syncope).
3. Confusing Antidotes or Critical Labs: Mixing up protamine sulfate (for heparin) with vitamin K (for warfarin). Another common error is not recognizing that a patient on digoxin with a low potassium level is at higher risk for toxicity, as hypokalemia potentiates digoxin’s effects.
4. Overusing Oxygen: Routinely administering oxygen to all patients with chest pain or dyspnea. Current guidelines stress that oxygen should only be given if the patient is hypoxic (SpO2 < 90-94%) as unnecessary oxygen can cause vasoconstriction and worsen outcomes.

Summary

• Heart Failure is classified by type (systolic/diastolic) and side (left/right). Compensatory RAAS activation ultimately worsens the condition, guiding pharmacologic management.
• Dysrhythmia intervention is based on patient stability. Know that VFib and pulseless VTach require immediate defibrillation, while AFib management prioritizes stroke prevention with anticoagulation.
• Acute Coronary Syndrome management hinges on rapid ECG interpretation. STEMI requires immediate reperfusion (PCI or fibrinolytics). Initial care follows MONA protocol.
• Cardiac Medications require vigilant monitoring: check renal function and potassium with ACEIs/ARBs, monitor heart rate with beta-blockers, watch electrolytes with diuretics, and know the key antidotes for digoxin, heparin, and warfarin toxicity.